Tag: 22nd

Latest News

MEDIA ADVISORY: Fabric Genomics™ Senior Scientist to Discuss Role of Genomics and Artificial Intelligence in Advancing Precision Medicine – Tuesday, January 22nd

Newsemia
OAKLAND, Calif.–(BUSINESS WIRE)–Fabric Genomics™ senior scientist discusses how AI can enhance genomics' value in advancing precision medicine Source link...
Latest News

22nd Century Group, Inc. presenta solicitud para producto de tabaco de riesgo modificado (MRTP) ante la FDA para los cigarrillos con bajo contenido de nicotina

Newsemia
WILLIAMSVILLE, N.Y. WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Files MRTP Application with FDA for Very Low Nicotine Cigarettes; VLN cigarettes contain 95% less nicotine than 100 leading...
Latest News

22nd Century stellt Antrag bei der FDA für Tabakprodukt mit modifiziertem Risiko (MRTP) bezüglich seiner Zigaretten mit sehr niedrigem Nikotingehalt

Newsemia
WILLIAMSVILLE, New York–(BUSINESS WIRE)–Die 22nd Century Group, Inc. (NYSE American: XXII), ein Pflanzenbiotechnologie-Unternehmen mit Fokus auf Reduzierung der Gesundheitsschädigung durch Tabak und auf Tabak mit...
Latest News

22nd Century dient MRTP-aanvraag (Modified Risk Tobacco Product, Gewijzigd risico tabaksproducten) in bij de FDA voor de sigaretten met een zeer laag nicotinegehalte van het bedrijf

Newsemia
WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), een bedrijf in plantenbiotechnologie dat gericht is op tabaksschadebeperking en VLN-tabak (Very Low Nicotine tobacco, tabak...
Latest News

22nd Century Files Modified Risk Tobacco Product (MRTP) Application with the FDA for the Company’s Very Low Nicotine Content Cigarettes

Newsemia
WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Files MRTP Application with FDA for Very Low Nicotine Cigarettes; VLN cigarettes contain 95% less nicotine than 100 leading US brands...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy